Indo-MIM IPO: The Bengaluru Firm That Injects Metal Like Plastic

Somewhere on the outskirts of Bengaluru, a machine is squirting metal into a mould the way a soft-serve machine squirts ice cream. Out come parts smaller than your thumbnail — the locking mechanism inside an aircraft seat, a tooth on a surgical stapler, a component buried deep inside a car's fuel system. You will never see one of these parts. You have almost certainly used dozens of them.

The company behind a lot of them is Indo-MIM, and in late July 2026 it's asking public investors to come along for the ride.

First, what does the company actually do?

Indo-MIM, founded in 1996 and headquartered in Bengaluru, is a precision engineering manufacturer built around a technology called Metal Injection Moulding (MIM).

Traditional metal parts are made by carving away material — you take a block and mill, cut and grind it into shape. That's slow, wasteful, and painful for tiny complex shapes. MIM flips it. Fine metal powder is mixed with a binder to create a paste that behaves like plastic, injected into a mould at high volume, then the binder is removed and the part is baked (sintered) until it becomes solid metal.

The revenue model, in plain terms

Indo-MIM doesn't sell to you. It sells to manufacturers — a business-to-business model spread across automotive, aerospace, defence, medical devices, consumer products and industrial customers. Revenue comes from long-run supply contracts for specific components, usually designed jointly with the client.

That last detail is the quiet moat. Once a component is designed into an aircraft assembly or a medical device, switching suppliers means re-qualifying the part — a slow, expensive, regulator-watched process. Customers rarely bother. So a won contract tends to stay won for years.

What the IPO looks like

The issue is scheduled to open on 23 July 2026 and close on 27 July 2026, with allotment expected around 28 July and a tentative listing on the BSE and NSE on 30 July 2026. It combines a fresh issue of ₹500 crore with an offer for sale of about 6.83 crore shares by existing shareholders. The fresh money is earmarked primarily to repay borrowings, which cuts interest costs and strengthens the balance sheet.

The price band had not been announced at the time of writing — which matters more than most people realise, because a good business at a bad price is still a bad investment. New to how this all works? Start with our what is an IPO explainer, and you'll need a demat account to apply.

Strengths worth noting

• Scale in a niche: the company operates what it describes as the world's largest installed MIM manufacturing capacity, which brings cost advantages rivals struggle to match.
• Diversified end markets: automotive, aerospace, defence, medical and industrial customers rarely all slow down at the same time.
• Sticky customers: once a part is qualified into a customer's assembly, switching suppliers is costly and slow.
• Balance sheet repair: fresh proceeds going towards debt repayment reduce interest outgo and financial risk.
• Export and 'China+1' tailwind: global manufacturers looking to diversify supply chains away from a single country favour established Indian suppliers.

And the risks — read these twice

• Customer concentration: B2B component makers often depend on a handful of large clients, so losing one can hurt disproportionately.
• Cyclicality: automotive and industrial demand rises and falls with the global economy, taking order books along for the ride.
• Currency and export exposure: a large export share means rupee swings and trade or tariff changes flow straight into earnings.
• Input costs: metal powders and energy are meaningful costs; sharp increases squeeze margins unless passed on.
• Offer for sale size: a large OFS means much of the money goes to existing shareholders rather than into the business — worth checking who is selling and how much.
• Valuation unknown at the time of writing: without a price band, no one can judge whether the business is being offered cheap or dear.

Boring businesses making invisible parts are often the most interesting to analyse — because nobody buys them for the story, so the numbers have to do the talking.

The lessons for investors

Indo-MIM is a useful teaching case for three habits. One: understand the technology well enough to explain it to a friend — if you can't, you can't judge whether the moat is real. Two: separate the fresh issue from the offer for sale, because only fresh money strengthens the company. Three: wait for the price. Enthusiasm about a business is not the same as a view on its shares, and the price band is what converts one into the other.

If you'd like to see how differently companies in other sectors earn, compare this with our Manipal Health hospital case study — one earns per occupied bed, the other per component shipped, and the risks are almost entirely different.

The company has spent three decades making things nobody notices. Whether that translates into a good investment depends entirely on the price attached to it — and on your own homework, not on listing-day noise.

Over to you: do you find it easier to evaluate a business you can see (a hospital, a bank) or one you'll never encounter (a component maker)? Tell us which you'd rather research. This article is educational and not investment advice.